Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer.
genitourinary oncology
patient-reported outcomes
prostate cancer
radionuclide therapy
radiopharmaceuticals
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
11
10
2022
revised:
20
12
2022
medline:
5
6
2023
pubmed:
13
1
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
The field of radionuclide therapy (RNT) for prostate cancer (PC) is growing rapidly, with recent Food and Drug Administration approval of the first
Identifiants
pubmed: 36635088
pii: jnumed.122.264946
doi: 10.2967/jnumed.122.264946
pmc: PMC10241017
doi:
Substances chimiques
Radioisotopes
0
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
869-872Subventions
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States
Informations de copyright
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Références
N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
Oncotarget. 2017 Jan 10;8(2):3581-3590
pubmed: 27683041
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
Lancet. 2021 Feb 27;397(10276):797-804
pubmed: 33581798
J Nucl Med. 2021 Oct;62(10):1440-1446
pubmed: 34016732
Cancer. 2020 Apr 1;126(7):1550-1558
pubmed: 31914209
Health Qual Life Outcomes. 2003 Dec 16;1:79
pubmed: 14678568
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Urology. 1997 Dec;50(6):920-8
pubmed: 9426724
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Lancet Oncol. 2006 Nov;7(11):903-9
pubmed: 17081915
JAMA. 2017 Jul 11;318(2):197-198
pubmed: 28586821